Why is Jubilant Pharmo falling/rising?

As of 18-Jul, Jubilant Pharmova Ltd's stock price is rising, currently at 1,234.90, reflecting an increase of 32.9 points or 2.74%. The stock has been on an upward trend, gaining for the last three consecutive days with a total return of 3.16% during this period. It has outperformed its sector by 3.29% today and is trading above all its moving averages, indicating strong momentum. Additionally, the company has shown impressive performance over the past year, with a return of 69.40%, while its profits have surged by 97.1%. Positive factors contributing to this rise include a significant growth in operating profit, consistent positive results over the last seven quarters, and a low debt-equity ratio, which enhances its attractiveness to investors. However, it is important to note that there are concerns regarding long-term growth due to a decline in net sales and operating profit over the last five years. In the broader market context, Jubilant Pharmova's short-term performance stands in stark contrast to the benchmark, as it has gained 6.74% over the past week while the Sensex has declined by 0.90%. This outperformance is indicative of strong investor confidence in the company relative to the overall market conditions. The stock's ability to maintain high institutional holdings at 24.27% further supports its stability and growth potential, as these investors typically have better resources to analyze the company's fundamentals. Overall, the combination of strong recent performance, positive financial indicators, and favorable market sentiment has contributed to the stock's rising price.